Solar urticaria

Photodermatology

Volumn , Issue , 2007, Pages 185-197

  Horio, Takeshi ^a   Holzle, Erhard ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KLINIKUM OLDENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551469993     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (61)

1. Humphreys F, Hunter JAA. The characteristics of urticaria in 390 patients. Br J Dermatol 1998; 138:635-638.
2. Magnus IA. Solar urticaria. In: Magnus IA, ed. Dermatological Photobiology. Oxford: Blackwell Scientific Publications, 1976:202-210.
3. Frain-Bell W. Solar urticaria. In: Frain-Bell W, ed. Cutaneous Photobiology. Oxford: Oxford University Press, 1985:51-55.
4. Reinauer S, Leenutaphong V, Hölzle E. Fixed solar urticaria. J Am Acad Dermatol 1993; 29:161-165.
5. Schwarze HP, Marguery MC, Journe F, Loche E, Bazex J. Fixed solar urticaria to visible light successfully treated with fexofenadine. Photodermatol Photoimmunol Photomed 2001; 17:39-41.
6. Ryckaert S, Roelandts R. Solar urticaria-a report of 25 cases and difficulties in phototesting. Arch Dermatol 1998; 134:71-74.
7. Monfrecola G, Nappa P, Pini D. Solar urticaria with delayed onset; a case report. Photodermatol Photoimmunol Photomed 1988; 5:103-104.
8. Ravits M, Armstrong RB, Harber LC. Solar urticaria; clinical features and wavelength dependence. Arch Dermatol 1982; 118:228-231.
9. Murphy GM, Hawk JLM. Broadening of action spectrum in a patient with solar urticaria. Clin Exp Dermatol 1987; 12:455-456.
10. Ng JCH, Foley PA, Crouch RH, Baker CS. Changes of photosensitivity and action spectrum with time in solar urticaria. Photodermatol Photoimmunol Photomed 2002; 18:191-195.
11. Hasei K, Ichihashi M. Solar urticaria; detection of action and inhibition spectra. Arch Dermatol 1982; 118:346-350.
12. Leenutaphong V, von Kries R, Holzle E, Plewig G. Solar urticaria induced by visible light and inhibited by UVA. Photodermatol 1988; 5:170-174.
13. Horio T, Yoshioka A, Okamoto H. Production and inhibition of solar urticaria by visible light exposure. J Am Acad Dermatol 1984; 11:1094-1099.
14. Horio T, Fujigaki K. Augmentation spectrum in solar urticaria. J Am Acad Dermatol 1988; 18:1189-1193.
15. Miyauchi H, Horio T. Detection of action, inhibition and augmentation spectra in solar urticaria. Dermatology 1995; 191:286-291.
16. Danno K, Mori N. Solar urticaria: report of two cases with augmentation spectrum. Photodermatol Photoimmunol Photomed 2000; 16:30-33.
17. Rajka E. Passive transfer in light urticaria. Clin Immunol 1942; 13:327-345.
18. Kojima M, Horiko T, Nakamura Y, Aoki T. Solar urticaria; the relationship of photoallergen and action spectrum. Arch Dermatol 1986; 122:550-555.
19. Kligman AM, Breit R. The identification of phototoxic drugs by human assay. J Invest Dermatol 1968; 51:90-99.
20. Kaidbey KH, Kligman AM. Identification of systemic phototoxic drugs by human intradermal assay J Invest Dermatol 1978; 70:272-274.
21. Epstein S. Urticaria photogenica. Ann Allergy 1949; 7:443-457.
22. Leenutaphong, V., Holzle, E., Plewig, G. Pathomechanism and classification of solar urticaria: a new concept. J Am Acad Dermatol 1989; 21:237-240.
23. Horio T, Minami K. Solar urticaria: photoallergen in a patient's serum. Arch Dermatol 1977; 113:157-160.
24. Horio T. Photoallergic urticaria induced by visible light: additional cases and further studies. Arch Dermatol 1978; 114:1761-1764.
25. Horio T. Solar urticaria-sun, skin and serum. Photodermatol 1987; 4:115-117.
26. Uetsu N, Miyauchi-Hashimoto H, Okamoto H, Horio T. The clinical and photobiological characteristics of solar urticaria in 40 patients. Br J Dermatol 2000; 142:32-38.
27. Crow KD, Alexander E, Buck WHL, Johnson BE, Magnus IA, Porter AD. Photosensitivity due to pitch. Br J Dermatol 1961; 73:220-232.
28. DeLeo VA, Hanson S, Scheide S. Benoxaprofen photosensitization of phospholipase activation in mammalian cells in culture. Toxicol Lett 1986; 32:215-220.
29. Kurumaji Y, Shono M. Drug-induced solar urticaria due to repirinast. Dermatology 1994; 188:117-121.
30. Horio T. Chlorpromazine photoallergy: coexistence of immediate and delayed type. Arch Dermatol 1975; 111:1469-1471.
31. Hawk JLM, Eady RAJ, Challoner AVJ, Kobza-Black A, Keahey TM, Greaves MW. Elevated blood histamine levels and mast cell degranulation in solar urticaria. Br J Clin Pharmacol 1980; 9:183-186.
32. Soter NA, Wasserman SI, Pathak MA, Parish JA, Austen KF. Solar urticaria: release of mast cell mediators in to the circulation after experimental challenge. J Invest Dermatol 1979; 72:282.
33. Sams WM Jr, Epstein JH, Winkelmann RK. Solar urticaria: investigation of pathogenetic mechanisms. Arch Dermatol 1969; 99:390-397.
34. Norris PG, Murphy GM, Hawk JLM, Winkelmann RK. A histological study of the evolution of solar urticaria. Arch Dermatol 1988; 124:80-83.
35. Leiferman KM, Norris PG, Murphy GM, Hawk JLM, Winkelmann RK. Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol 1989; 21:75-80.
36. Armstrong RB, Horan DB, Silver DN. Leukocytoclastic vasculitis in urticaria induced by ultraviolet irradiation. Arch Dermatol 1985; 121:1145-1148.
37. Behrendt, H., Lehmann, P., Leenutaphong, V., Holzle, E., Plewig, G. Sequential ultrastructural analysis of solar urticaria: inflammatory cells, blood vessels, and nerve fibers. J Invest Dermatol 1989; 92:400a.
38. Beattie, PE, Dawe RS, Ibbotson SH, Ferguson J. Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases. Arch Dermatol 2003; 139(9):1149-1154.
39. Magnus IA, Jarrett A, Prankerd TAJ, Rimington C. Erythropoietic protoporphyria: a new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet 1961; 2:448-451.
40. Dawe RS, Clark C, Ferguson J. Porphyria cutanea tarda presenting as solar urticaria. Br J Dermatol 1999; 141:590-591.
41. Rantanen T, Suhonen R. Solar urticaria. A case with increased skin mast cells and good therapeutic response to an antihistamine. Acta Derm Venereol (Stockh) 1980; 60:363-365.
42. Monfrecola G, Masturzo E, Riccardo AM, Balato F, Ayala F, Di Costanzo MP. Solar urticaria: a report on 57 cases. Am J Contact Dermat 2000; 11(2):89-94.
43. Holzle E. The idiopathic photodermatoses: solar urticaria. In: Hawk JLM, ed. Photodermatology London: Arnold, 1999:113-125.
44. Harber LC, Bickers DR. Solar urticaria. In: Harber LC, Bickers DR, eds. Photosensitivity Diseases. 2nd ed. Toronto: B. C. Decker, 1989:209-218.
45. Diffey BL, Farr PM. Treatment of solar urticaria with terfenadine. Photodermatol 1988; 5:25-29.
46. Dawe RS, Ferguson J. Prolonged benefit following ultraviolet A phototherapy for solar urticaria. Br J Dermatol 1997; 137(1):144-148.
47. Beissert S, Stander H, Schwarz T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 2000; 42(6):1030-1032.
48. Leenutaphong V, Holzle E, Plewig G. Solar urticaria: study on mechanisms of tolerance Br J Dermatol 1990; 122:601-606.
49. Keahey TM, Lavker RM, Kaidbey KH, Atkins PC, Zweiman B. Studies on the mechanism of clinical tolerance in solar urticaria.Br J Dermatol 1984; 110:327-338.
50. Holzle E, Hofmann C, Plewig G. PUVA-treatment for solar urticaria and persistent light reaction. Arch Dermatol Res 1980; 269:87-91.
51. Parrish JA, Jaenicke KF, Morison WL, Momtaz K, Shea C. Solar urticaria: treatment with PUVA and mediator inhibitors. Br J Dermatol 1982; 106:575-580.
52. Christophers E, Hönigsmann H, Wolff K, Lagner A. PUVA treatment of urticaria pigmentosa. Br J Dermatol 1978; 98:701-702. Dermatology 1997; 195(1):35-39.
53. Midelfart K, Moseng D, Kavli G, Stenvold SE, Volden G. A case of chronic urticaria and vitiligo, associated with thyroiditis, treated with PUVA. Dermatologica 1983; 167:39-41.
54. Olafsson JH, Larkö O, Roupe G, Granerus G, Bengtsson U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Arch Dermatol Res 1986; 278:228-231.
55. Danno K, Toda K, Horio T. The effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells: PUVA suppresses degranulation of mouse skin mast cells induced by compound 48/80 or concanavalin A. J Invest Dermatol 1985; 85:110-114.
56. Toda K, Danno K, Tachibana T, Horio T. Effect of 8-methoxypsoralen plus long-wave ultraviolet (PUVA) radiation on mast cells. II. In vitro PUVA inhibits degranulation of rat peritoneal mast cells induced by compound 48/80. J Invest Dermatol 1986; 87:113-116.
57. Edstrom DW, Ros AM. Cyclosporin A therapy for severe solar urticaria. Photodermatol Photoimmunol Photomed 1997; 13(1-2):61-63.
58. Duschet P, Leyen P, Schwarz T, Hocker P, Greiter J, Gschnait F. Solar urticaria: treatment by plasmapheresis. J Am Acad Dermatol 1986; 15:712-713.
59. Leenutaphong V, Holzle E, Plewig G, Grabensee B, Kutkuhn B. Plasmapheresis in solar urticaria. Photodermatol 1987; 4:308-309.
60. Hudson-Peacock MJ, Farr PM, Diffey BL, Goodship TH. Combined treatment of solar urticaria with plasmapheresis and PUVA. Br J Dermatol 1993; 128:440-442.
61. Mang R, Stege H, Budde MA, Ruzicka T, Krutmann J. Successful treatment of solar urticaria by extracorporeal photochemotherapy (photopheresis)-a case report. Photodermatol Photoimmunol Photomed 2002; 18(4):196-198.